Matsumoto, Hideki
Miura, Naoki
Naito, Masaki
Elango, Rajavel
Funding for this research was provided by:
AJINOMOTO CO., INC.
Article History
Received: 31 March 2025
Accepted: 6 May 2025
First Online: 27 May 2025
Declarations
:
: HM, MN are employed by Ajinomoto Co., Inc., Tokyo, Japan. NM, RE declares no conflict of interest.
: The procedures in the clinical trials were in accordance with ethical standards and were approved by the Ajinomoto Co., Inc ethics review committee (2022-021) and the Miura Medical Clinic ethics review committee (R2212).